Mumbai, India has emerged as a key hub for the production of Acalabrutinib Active Pharmaceutical Ingredient (API), with several companies excelling at its development. Notably, certain manufacturers in this region are recognized for their high-quality Acalabrutinib (CAS 1420477-60-6) production,